EC pharmaceutical regulatory reform plan
EU Commissioner Erkki Liikanen last week outlined the Commission's plans for reform of the EU's pharmaceutical legislation. The Commission's key proposals are the introduction of fast-track registration, conditional marketing authorization, and removal of the marketing authorization renewal procedure. For patients, the Commission wants to provide more transparency and access to data on the Internet.
In a speech before the Mentor Group